.
Several recent studies have shown that bacteria either grown in vitro as adherent biofilms or recovered from infected prosthetic devices have decreased susceptibilities to antimicrobial killing. To further study the microbial and environmental factors responsible for this decreased antibiotic susceptibility, we developed an in vitro model of surface-adherent Staphylococcus aureus growing on polymethylmethacrylate coverslips coated with pure fibronectin. After exponential growth for 4 h, the population of fibronectin-attached S. aureus remained constant for a further 48-h period, as evaluated by CFU counts of organisms quantitatively removed from the coverslips. At selected time points, surface-bound organisms were exposed to bactericidal concentrations of either oxacillin, vancomycin, fleroxacin, or gentamicin in short-term (0.5 to 2 h) or long-term (24 h) killing assays. Whereas at 2 h surface-growing organisms were still optimally killed by all antimicrobial agents, at 4 and 24 h attached bacteria expressed markedly altered susceptibilities to these agents. The decrease in susceptibility was moderate for fleroxacin, more important for oxacillin and vancomycin, and extensive for gentamicin. When surface-attached S. aureus was compared with bacteria grown in a fluid phase, both populations showed a parallel time-dependent decrease in their susceptibilities to either oxacillin, vancomycin, or fleroxacin. In contrast, attached organisms became considerably more resistant to gentamicin than suspended bacteria did. Subpopulations of organisms spontaneously released from coverslips during antibiotic exposure also showed markedly reduced susceptibilities to antimicrobial killing. This simple model of S. aureus colonization of in vitro fibronectin-coated surfaces might represent a useful approach to the study of the physiological and biochemical changes that underlie the decreased antibiotic susceptibilities of biomaterialattached organisms.
Infection is a major complication in patients with implanted devices. Several clinical (3, 4, 23) and experimental (11, 21) studies have documented the frequent failure of antimicrobial agents to eradicate staphylococcal infections associated with orthopedic prostheses, central nervous system shunts, or artificial valves. The reasons for this lack of effectiveness are still poorly understood and may involve alterations in the properties of the bacteria that colonize implants, impairment in the host defense mechanisms (41, 43) , or both.
Tissue cage models of foreign body infection, whether subcutaneously implanted in guinea pigs (38, 39) or rats (8, 25) , have further documented the lack of in vivo efficacy of several antistaphylococcal agents that are highly active in vitro. Tissue cage models, which reproduce characteristics typical of those of clinical foreign body infections (42, 43) , have also demonstrated that the impaired in vivo efficacies of antimicrobial agents occurred despite the presence of adequate antibiotic concentrations at the true site of infection, namely, in the inflammatory exudative fluid produced by tissue cages (8, 25, 38, 39) .
In a recent study (9) (1, 10, 19, 22, 34, 40) , but some investigators have reported that resistance is independent of bacterial slime-producing characteristics (20, 31 (29) .
Attachment and growth of S. aureus 120 on fibronectincoated surfaces. Procedures for adsorption of fibronectin on coverslips and adhesion of S. aureus I20 in suspension have previously been described in detail (35, 36) . Briefly, ethanolcleaned and heat-sterilized polymethylmethacrylate coverslips (8 by 8 mm) were coated individually with a monolayer of fibronectin (300 ng/cm2) by incubation for 1 h at 37°C in a 1-ml volume of PBS containing 10 jg of purified fibronectin. After being rinsed, each fibronectin-coated coverslip was incubated for 60 min in a shaking water bath at 37°C with a 1-ml suspension containing 108 CFU of washed log-phase S.
aureus I20 in PBS with 1 mM Ca2" and Mg +. These organisms came from an overnight culture which was diluted to 2 x 107 CFU/ml in IST broth, and the organisms were grown for 3 h. When indicated, [3H]thymidine was added to the 3-h culture. At the end of the attachment period, the fluids containing unbound bacteria were drained. Coverslips were rinsed twice in 1 ml of PBS and were transferred to new tubes containing 1 ml of IST broth. They were then incubated at 37°C without agitation to allow growth of attached organisms for various periods of time ranging from 2 to 48 h. The number of surface-bound S. aureus 120 organisms resulting from growth on fibronectin-coated coverslips in IST broth was estimated by measuring the CFU counts of the bacteria removed from the solid phase by the following methods. At the end of the incubation, the fluids containing spontaneously released bacteria were drained; after gentle rinsing in PBS, the coverslips were transferred to tubes containing 1 ml of PBS with 100 pg of bovine trypsin (Serva, vancomycin could reduce the colony counts of stationaryphase organisms by even 0.5 log1o CFU (Fig. 1A and B) .
Surface-bound and fluid-phase S. aureus I20 were also exposed to cell wall-active antibiotics in long-term (24-h) killing assays. Both actively growing and stationary-phase organisms tested at 2, 4, or 24 h were significantly killed (>3 log1o CFU) by both oxacillin and vancomycin ( Fig. 1C and   D) .
The susceptibility of either surface-bound or fluid-phase S. aureus I20 to a bactericidal (8 p,g/ml) concentration of either fleroxacin or gentamicin was also tested at selected time points (Fig. 2) . In short-term (1-h) killing assays performed with fleroxacin, the average reduction in CFU was not significantly different for solid-and fluid-phase organisms, reaching 2.53 and 2.80 log1o at 2 h, 1.95 and 2.38 log1o at 4 h, and 1.20 and 0.84 log1o at 24 h, respectively ( Fig. 2A and B) .
Long-term killing assays confirmed the similar susceptibilities to fleroxacin of attached and fluid-phase organisms, which were eradicated by more than 3.5 log1o CFU when tested at either 2 or 24 h (Fig. 2C and D) .
In contrast to its susceptibilities to other antibiotics, S. aureus 120 showed a progressive decrease in susceptibility to gentamicin which was selectively promoted by a surface location. Exponentially growing 2-h cultures in the solid phase were still susceptible to the bactericidal effect of gentamicin in short-term (30-min) killing assays, with an average decrease in CFU counts of 4.30 log1o (Fig. 2A) . At 4 h, the susceptibility of attached bacteria to gentamicin was sharply reduced (killing of 1.06 log1o CFU), while fluid-phase S. aureus I20 tested in short-term assays was killed by >3 log1o CFU ( Fig. 2A and B) . At 24 h, both attached and fluid-phase bacteria were initially (30-min incubation) resistant to the killing effect of gentamicin, but a longer incubation period with the drug resulted in a selective resistance of the surface-bound organisms versus the fluid-phase ones, with a decrease in CFU of 1.05 log1o for the former and more than 6 log1o CFU for the latter (Fig. 2C and D) .
To further analyze whether the antibiotic susceptibility changes observed on S. aureus I20 attached to fibronectincoated surfaces were specific to the solid-phase location at the time of the assay or reflected more permanent metabolic changes, control experiments were performed. In those experiments, the organisms were removed from coverslips and tested in the liquid phase. As shown in Fig. 1A and 2A, bacteria freshly removed from the coverslips at either 4 or 24 h and tested in dilute suspensions of 106 CFU/ml were killed by either oxacillin, vancomycin, or fleroxacin at exactly the same rate as the more densely packed surface-bound organisms were. The only notable exception was gentamicin, which, at 4 h, but not at 24 h, was more active on dilute, freshly suspended bacteria than on surface-bound organisms ( Fig. 2A) . Additional experiments testing the influence of various cell densities of S. aureus 120 on the bactericidal activity of each antibiotic were performed on bacteria in suspension. Liquid-phase cultures of S. aureus I20 in the stationary phase (24 h) were diluted to either 106 or 108 CFU/ml and were exposed to short-term bactericidal assays. Since organisms at both inocula were killed similarly by each antibiotic ( Fig. 1B and 2B) , this indicated that cell density itself is not a critical factor that interferes with the bactericidal assays.
A further important environmental parameter known to influence bactericidal activity is limitation of essential nutrients. This possibility was excluded by performing control experiments which showed equivalent growth rates of solidand liquid-phase cultures of S. aureus I20 in either undiluted or 10-fold-diluted IST broth (data not shown).
Quantification of bacterial release during antibiotic exposure. To validate the long-term antibiotic killing assays performed on 24-h solid-phase cultures, it was important to exclude an excessive contribution of bacterial release to the observed decrease in viable counts ( Fig. 1 and 2 ). Since CFU counts were an unreliable parameter in the presence of antibiotics, we determined in a further set of experiments the proportion of cell-associated radioactivity which was released during antibiotic exposure. At 24 h, 20 to 30% of the initially attached radioactivity was still present on coverslips. The cellular location of this radioactivity was validated by control experiments which showed that >90% of the tritium counts of the 24-h bacterial culture were sedimentable by low-speed centrifugation and were retained by 0.22-,um-pore-size filters. These counts were quantitatively solubilized (>90%) by treatment of the bacterial culture with lysostaphin and DNase.
During the initial 30-min to 2-h incubation period, the radioactivity released from 24-h solid-phase cultures was less than 30%, regardless of the antibiotic tested. After 24 h of incubation with antibiotics, the proportion of released radioactivity averaged 65% for oxacillin-, vancomycin-, and fleroxacin-treated cultures and averaged 29% for gentamicintreated cultures (Fig. 3A) .
Despite the fact that the counts per minute released from the coverslips probably reflected those from a mixture of viable and killed organisms whose proportion was unknown, it was possible to predict how bacterial release could affect the accuracy of killing estimates obtained by CFU counts. In the hypothetical situation in which radioactivity release from the coverslips would exclusively involve viable bacteria, the reduction in CFU counts, as presented in Fig. 1 and 2 3 .59 for fleroxacin, and from 1.38 to 1.23 for gentamicin. Therefore, release of viable organisms during antibiotic exposure was not an important reason for the decrease in CFU counts of antibiotic-exposed organisms on coverslips.
The unknown proportion of bacteria leaving coverslips as viable versus killed units did not allow a precise measurement of bacterial killing in the fluid phase; however, we could make an estimation of this killing by recording the cumulative survival of attached and released bacteria during antibiotic exposure. Viable counts of released organisms added to those of attached ones (Fig. 3B) The present study showed that S. aureus growing on surfaces is initially as susceptible to bactericidal antibiotics as fluid-phase bacteria. Longer incubation of the surfacebound organisms, up to the stationary phase, produced a significant decrease in their susceptibilities to antimicrobial killing. These susceptibility changes were not expressed to the same extent for all antibiotics, being moderate for fleroxacin, more important for oxacillin and vancomycin, and major for gentamicin. The susceptibilities of surfacebound and fluid-phase S. aureus decreased in a nearly parallel way for oxacillin, vancomycin, and fleroxacin. With gentamicin, bacterial susceptibility was far more affected when the bacteria were grown on the solid surface than when they were grown in the fluid phase. Not only surface-bound organisms but also those released from fibronectin-coated coverslips during antibiotic exposure were found to be significantly more resistant to antibiotic killing than bacteria grown and tested exclusively in the fluid phase.
A recent literature survey of studies of surface-bound microbial populations, frequently referred to as biofilms, revealed that in most cases bacteria tested for antibiotic susceptibility were grown for long periods, frequently exceeding 24 h (2, 14, 19, 20, 24, 32, (37) (38) (39) . A majority of investigators using either static experimental systems (20, 24, 38, 39) (2, 32) and Staphylococcus epidermidis (14, 19) . In these complex experimental conditions, it was difficult to sort out the individual contribution of several important parameters such as the thickness and composition of the exopolysaccharide layer, the high densities of adherent bacteria, the limitation of essential nutrients, altered metabolism, or slow growth rate. In our study with S. aureus I20, we found no evidence by microscopy for a significant exopolysaccharide layer surrounding fibronectin-attached organisms, thus excluding a possible influence of this parameter. Furthermore, we could minimize the potential effects of nutrient limitation by incubating surface-bound organisms in a rich liquid medium containing an excess of essential nutrients during growth and antibiotic testing.
Solid-and fluid-phase bacteria at equivalent growth phases showed parallel changes in their susceptibilities to oxacillin, vancomycin, and fleroxacin. This suggested that for these antibiotics growth rate and/or growth-related metabolic events play a major role in the susceptibility decrease of surface-bound organisms. In contrast, the rapid and substantial loss of susceptibility to gentamicin observed for solid-phase S. aureus was not related only to decreased growth rate, because fluid-phase organisms growing at similar rates remained more susceptible than adherent bacteria. Previous studies also described a drastic loss of aminoglycoside activity toward adherent populations of either S. epidermidis, P. aeruginosa, or Escherichia coli, which was explained either by a restricted drug penetration through thick bacterial biofilms (2, 19, 32) or by growth rate-related effects (13) . Because neither of these mechanisms could explain the loss of susceptibility to gentamicin of S. aureus I20 in our experimental system, we looked for the possible emergence of aminoglycoside-resistant variants during exposure to concentrations of gentamicin exceeding the MBC. Several studies have previously described the in vitro and in vivo production of small, nonhemolytic colonies showing increased resistance to aminoglycoside antibiotics. These so-called small-colony variants, which developed during therapy with aminoglycosides or in vitro exposure, were shown to have a defective energy-dependent transport system of aminoglycosides, which led to reduced intracellular accumulations and bactericidal activities of these antimicrobial agents (26) (27) (28) 33) . A careful screening of colony morphology during growth and antibiotic exposure of solidphase S. aureus did not show emergence of small-colony variants. Further experiments are planned to study the physiological parameters of gentamicin-tolerant populations of S. aureus during adhesion on fibronectin-coated surfaces.
Very few studies have estimated the antibiotic susceptibilities of bacteria spontaneously released from adherent biofilms. In one report (37) , the bacteria shed from biofilms of S. epidermidis and P. aeruginosa were described as having an intermediate response between those of the more resistant adherent organisms and the more susceptible fluidphase ones. In another experimental system of growth rate-controlled biofilms (16) , the susceptibilities of the released organisms varied widely, depending on the bacterial species; gram-negative bacilli were highly susceptible to antibiotics (12, 13, 15) , whereas S. epidernidis released from surfaces was more resistant to killing than surface-bound organisms were (15) . Our results are a further indication of the decreased susceptibility to antibiotic killing of S. aureus released from surfaces. These results might have some in vivo relevance. We have recently reported that S. aureus recovered from an experimental model of a chronically infected foreign body was resistant to antimicrobial agents when tested in vitro (9) . Not only surface-bound organisms but also those recovered from the fluid surrounding the foreign body-which might be shed bacteria-were killed slowly and incompletely by all the antibiotics tested. We hope that the simplified in vitro model reported here will help investigators to study the factors responsible for the resistance of in vivo-growing microorganisms to bactericidal agents.
In conclusion, the development of an in vitro model that made use of fibronectin-coated coverslip surfaces for promoting S. aureus attachment and colonization allowed us to study in detail how the susceptibilities of surface-bound organisms to different antibiotics were affected by growth rate, surface density, and other environmental parameters. The bacteria that colonize surfaces or that are spontaneously released from them represent an interesting subpopulation of S. aureus whose physiological and biochemical properties deserve further study.
